Last 47 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.97 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 349.20 | 1823.21 | 625.44 | 0.09 | — | — | — | 396.74 | 555.12 | 642.20 | 598.19 | 442.86 | 14.83 |
| — | — | — | -100.0% | — | — | — | -10.4% | +3642.5% | +1305.5% | +45.8% | -91.9% | -100.0% | |
| P/B Ratio | 0.92 | 1.57 | 1.02 | 0.00 | 1.40 | 1.50 | 1.28 | 1.45 | 1.81 | 2.27 | 2.25 | 2.69 | 1.78 |
| — | +5.2% | -20.4% | -99.8% | -22.8% | -34.2% | -43.0% | -46.1% | +1.6% | -74.2% | -98.7% | -98.9% | -100.0% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Ainos, Inc.'s operating margin was -128481.4% in Q3 2025, down 48153.6 pp QoQ. This marks the 3rd consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of -70595.8% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -153.7% | 78.0% | 79.9% | 82.8% | — | — | — | -29.1% | -559.7% | -258.8% | -95.5% | -105.1% | 44.3% |
| — | — | — | +385.0% | — | — | — | +72.4% | -1363.5% | -882.1% | -291.3% | -298.8% | -29.6% | |
| Operating Margin | -66772.2% | -128481.4% | -80327.8% | -2978.0% | — | — | — | -15051.8% | -28643.0% | -10926.0% | -8112.8% | -5111.5% | -204.9% |
| — | — | — | +80.2% | — | — | — | -194.5% | -13881.2% | -2355.2% | -2556.4% | -114.0% | +96.2% | |
| Net Margin | -71702.3% | -135288.5% | -87604.3% | -3094.0% | — | — | — | -15991.2% | -29765.4% | -12151.8% | -8228.8% | -5126.7% | -205.7% |
| — | — | — | +80.7% | — | — | — | -211.9% | -14368.8% | -2631.0% | -2567.7% | -112.9% | +96.2% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -74.4% | -27.3% | -33.3% | -22.9% | -27.8% | -19.1% | -14.7% | -14.1% | -22.7% | -10.2% | -7.5% | -7.5% | -6.0% |
| — | -42.9% | -125.8% | -63.1% | -22.1% | -86.4% | -96.6% | -86.9% | -278.2% | +72.2% | +73.1% | +67.2% | +43.1% | |
| ROA | -49.0% | -12.6% | -16.3% | -11.9% | -15.5% | -11.1% | -9.8% | -10.8% | -18.0% | -8.8% | -6.6% | -6.8% | -5.6% |
| — | -13.8% | -66.0% | -10.7% | +14.3% | -26.2% | -47.3% | -57.6% | -221.7% | +55.5% | -37.2% | -32.6% | -18.0% | |
| ROIC | -39.8% | -10.2% | -12.9% | -10.3% | -14.3% | -8.8% | -8.5% | -8.4% | -14.5% | -6.4% | -5.2% | -5.5% | -4.6% |
| — | -15.2% | -51.5% | -22.8% | +1.4% | -37.9% | -63.5% | -52.9% | -214.2% | +61.2% | -30.9% | +13.0% | +34.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has improved 116.5% YoY to 2.96x, strengthening the short-term liquidity position. Debt/Equity has risen for 10 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.77 | 1.10 | 0.96 | 0.91 | 0.77 | 0.68 | 0.67 | 0.25 | 0.24 | 0.19 | 0.10 | 0.11 | 0.04 |
| — | +60.8% | +43.3% | +265.0% | +217.0% | +254.8% | +540.5% | +127.3% | +565.8% | +449.1% | -98.0% | -97.2% | -89.7% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.10 | 2.96 | 2.88 | 2.00 | 1.10 | 1.37 | 1.48 | 0.32 | 1.85 | 3.71 | 1.92 | 1.95 | 1.15 |
| — | +116.5% | +95.0% | +524.4% | -40.7% | -63.1% | -23.2% | -83.5% | +60.8% | +167.3% | +263.1% | +268.9% | +1487.7% | |
| Quick Ratio | 1.06 | 2.67 | 2.61 | 1.91 | 1.06 | 1.33 | 1.45 | 0.28 | 1.72 | 3.44 | 1.45 | 1.64 | 0.91 |
| — | +101.2% | +80.6% | +570.8% | -38.5% | -61.4% | -0.1% | -82.6% | +89.5% | +206.6% | +234.0% | +249.9% | +1155.6% | |
| Interest Coverage | -22.45 | -15.77 | -21.05 | -17.53 | -25.13 | -11.48 | -25.67 | -64.07 | -113.25 | -60.44 | -57.47 | -271.01 | -258.58 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonAinos, Inc.'s current P/E is -1.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Ainos, Inc.'s current operating margin is -66772.2%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Ainos, Inc.'s business trajectory between earnings reports.